Harlow, United Kingdom

Eric Hunt

This inventor holds 22 USPTO granted patents and 1 EPO patent, primarily in Antimicrobial Compounds. Top assignees: Beecham Group Plc, Smithkline Beecham Corporation, Glaxo Group Limited. Active years: 1978-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eric Hunt. Retrieved from https://idiyas.com/inventor/eric-hunt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 81.8


Average Co-Inventor Count = 1.8

ph-index = 7

Forward Citations = 99(Granted Patents)


Location History:

  • Reigate, EN (1978)
  • Reigate, GB (1979 - 1980)
  • Betchworth, GB (1979 - 1997)
  • Harlow, GB (2005 - 2009)
  • Great Dunmow, GB (2000 - 2012)

Company Filing History:


Years Active: 1978-2012

Loading Chart...
Loading Chart...
Areas of Expertise:
Pleuromutilin Derivatives
Macrolides
Carbapenem Derivatives
Antibacterials
Heterocyclic Compounds
Erythromycin Derivatives
Clavulanic Acid
Beta-Lactam Antibiotics
Azetidinoyl Ethers
Oxaazabicycloheptane
Carbamoyloxy Derivatives
Thio Ethers
22 patents (USPTO):Explore Patents

Title: Eric Hunt: Innovator in Antimicrobial Solutions

Introduction

Eric Hunt, located in Harlow, GB, is a prolific inventor with a remarkable portfolio consisting of 22 patents. His contributions to the field of antimicrobial therapy have positioned him as an influential figure in medical innovation.

Latest Patents

Among his latest inventions are the "Pleuromutilin derivatives as antimicrobials," which focus on the development of pleuromutilin derivatives. This invention encompasses processes for their preparation, pharmaceutical compositions containing them, and their application in medical therapy, particularly in combating bacterial infections. Another noteworthy patent is "Ether linked macrolides useful for the treatment of microbial infections." This invention relates to 14- or 15-membered macrolides substituted at the 4″ position, along with the processes for their preparation, aimed at treating systemic or topical microbial infections in both humans and animals.

Career Highlights

Eric has had a distinguished career, working with prominent companies such as Beecham Group Plc and SmithKline Beecham Corporation. His experience in these organizations has undoubtedly contributed to his expertise in the pharmaceutical sector.

Collaborations

Throughout his career, Eric has collaborated with notable figures including Steven Dabbs and Colin Henry Frydrych. These partnerships have fostered a collaborative environment that has facilitated innovation and development in their respective fields.

Conclusion

Eric Hunt remains a key player in the innovation of antimicrobial therapies, with his extensive patent portfolio solidifying his status as a leader in pharmaceutical research and development. His work continues to impact the medical community positively, paving the way for new treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…